HeXun Biosciences Co., Ltd. (6986.TWO)

TWD 76.7

(-1.29%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021
Revenue 130.57 Million 49.46 Million -
Cost of Revenue 16.83 Million 4.85 Million -
Gross Profit 113.73 Million 44.61 Million -
Operating Expenses 86.35 Million 53.58 Million 50.66 Million
Selling, General and Administrative Expenses 33.14 Million 14.22 Million 5.95 Million
Research and Development Expenses 53.21 Million 39.36 Million 44.7 Million
Other Expenses - 4.97 Million 9.21 Million
Cost and Expenses 103.19 Million 58.44 Million 50.66 Million
Operating Income 27.37 Million -3.54 Million -41.41 Million
Interest Expense 1.85 Million 1.63 Million 1.57 Million
Income Tax Expense - - -
Earnings before Tax 33.48 Million -5.18 Million -42.98 Million
Net Income 33.48 Million -5.18 Million -42.98 Million
Earnings Per Share Basic 0.89 -0.14 -1.41
Earnings Per Share Diluted 0.89 -0.14 -1.41
Weighted Average Shares Outstanding 37.5 Million 37.5 Million 30.5 Million
Weighted Average Shares Outstanding (Diluted) 37.5 Million 37.5 Million 30.5 Million
Gross Margin 0.87 0.90 -
EBIT Margin 0.43 0.23 -
Profit Margin 0.26 -0.10 -
EBITDA 55.64 Million 11.17 Million -29.5 Million
Earnings Before Tax Margin 0.21 -0.07 -

Income Statement Charts